NCT02261532 2024-11-14A Phase I Study of TAS-102 in Solid TumorsTaiho Pharmaceutical Co., Ltd.Phase 1 Completed15 enrolled 7 charts
NCT04074343 2024-02-02TAS-102 and Irinotecan in 2L+ Gastric and Gastroesophageal AdenocarcinomaUniversity of California, IrvinePhase 1 Completed20 enrolled 9 charts